World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
26467
World Ranking
12779
National Ranking
6529

Gaston K. Rivera publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gaston K. Rivera sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 234 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gaston K. Rivera D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gaston K. Rivera sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gaston K. Rivera is affiliated with St. Jude Children's Research Hospital in the United States. Their research spans various topics within medicine, focusing primarily on pediatric and neurological conditions with an emphasis on leukemia and neurodegenerative diseases.

The primary fields of study for Rivera include medicine, with subfields covering public health, environmental and occupational health, pediatrics, perinatology and child health, neurology, hematology, and artificial intelligence.

Key research topics addressed by Rivera encompass:

  • Acute Lymphoblastic Leukemia research
  • Childhood Cancer Survivors' Quality of Life
  • Acute Myeloid Leukemia Research
  • Neuroblastoma Research and Treatments
  • Machine Learning in Healthcare
  • Intracerebral and Subarachnoid Hemorrhage Research

The scientist's publication record includes papers in several peer-reviewed journals, with a focus on leukemia and neurological disorders. Recent notable publications include:

  • Reduced-dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study, 2020, Blood
  • Reduced-intensity therapy for pediatric lymphoblastic leukemia: impact of residual disease early in remission induction, 2020, Blood
  • From Microbleeds to Iron: AI Prediction of Cerebrospinal Fluid Erythrocyte Load in Alzheimer's Disease, 2025, Journal of Clinical Medicine
  • Magnetic Resonance Imaging and Cerebrospinal Fluid Biomarker Clustering Defines Biological Subtypes of Alzheimer's Disease, 2025, Biomedicines
  • Interpretable Machine Learning for Risk Stratification of Hippocampal Atrophy in Alzheimer's Disease Using CSF Erythrocyte Load and Clinical Data, 2025, Biomedicines

Frequent publication venues for Rivera include:

  • Biomedicines
  • Blood
  • Journal of Clinical Medicine

Collaboration is evident in Rivera's work, with frequent coauthors such as Rafail C. Christodoulou, Georgios Vamvouras, Maria Daniela Sarquis, Vasileia Petrou, and Platon S. Papageorgiou, each contributing to multiple joint publications.

Best Publications

  • Mercaptopurine Therapy Intolerance and Heterozygosity at the Thiopurine S-Methyltransferase Gene Locus

    Mary V. Relling;Michael L. Hancock;Gaston K. Rivera;John T. Sandlund

  • Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.

    C H Pui;R C Ribeiro;M L Hancock;G K Rivera

  • Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.

    Elaine Coustan-Smith;Jose Sancho;Michael L. Hancock;James M. Boyett

  • Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

    Elaine Coustan-Smith;Frederick G. Behm;Frederick G. Behm;Joaquin Sanchez;James M. Boyett;James M. Boyett

  • Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia.

    Ching-Hon Pui;Frederick G. Behm;Susana C. Raimondi;Richard K. Dodge

  • Improved outcome for children with acute lymphoblastic leukemia: Results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

    Ching Hon Pui;John T. Sandlund;Deqing Pei;Dario Campana

  • Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia.

    Ching Hon Pui;Cheng Cheng;Wing Leung;Shesh N. Rai

  • Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

    G.K. Rivera;G.K. Rivera;C.-H. Pui;C.-H. Pui;M. Abromowitch;M. Abromowitch;J. Mirro;J. Mirro

  • High incidence of secondary brain tumours after radiotherapy and antimetabolites

    Mary V. Relling;Mary V. Relling;Jeffrey E. Rubnitz;Jeffrey E. Rubnitz;Gaston K. Rivera;Gaston K. Rivera;James M. Boyett;James M. Boyett

  • Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis.

    Walter T. Hughes;Gaston K. Rivera;Michael J. Schell;Delaine Thornton

  • Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia.

    Elaine Coustan-Smith;Jose Sancho;Frederick G. Behm;Michael L. Hancock

  • Cumulative Incidence of Secondary Neoplasms as a First Event After Childhood Acute Lymphoblastic Leukemia

    Nobuko Hijiya;Melissa M. Hudson;Shelly Lensing;Margie Zacher

  • Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.

    S B Murphy;W P Bowman;M Abromowitch;J Mirro

  • Higher Frequency of Glutathione S-Transferase Deletions in Black Children With Acute Lymphoblastic Leukemia

    Chun-Lin Chen;Qing Liu;Ching-Hon Pui;Gaston K. Rivera

  • Treatment of acute lymphoblastic leukemia : 30 years' experience at St. Jude Children's Research Hospital

    Gaston K. Rivera;Donald Pinkel;Joseph V. Simone;Michael L. Hancock

  • Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia

    AT Look;PK Roberson;DL Williams;G Rivera

  • Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research hospital

    Andrew W. Walter;Michael L. Hancock;Ching Hon Pui;Melissa M. Hudson

  • Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia

    DL Williams;A Tsiatis;GM Brodeur;AT Look

  • Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age.

    Frederick G. Behm;S. C. Raimondi;J. L. Frestedt;Q. Liu

  • Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital.

    C. H. Pui;J. M. Boyett;G. K. Rivera;M. L. Hancock

Frequent Co-Authors

Ching-Hon Pui
Ching-Hon Pui St. Jude Children's Research Hospital
Raul C. Ribeiro
Raul C. Ribeiro St. Jude Children's Research Hospital
John T. Sandlund
John T. Sandlund National Institutes of Health
William E. Evans
William E. Evans St. Jude Children's Research Hospital
Frederick G. Behm
Frederick G. Behm University of Illinois at Chicago
Susana C. Raimondi
Susana C. Raimondi St. Jude Children's Research Hospital
Mary V. Relling
Mary V. Relling St. Jude Children's Research Hospital
William M. Crist
William M. Crist University of Oklahoma
Jeffrey E. Rubnitz
Jeffrey E. Rubnitz St. Jude Children's Research Hospital
Sharon B. Murphy
Sharon B. Murphy Lurie Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees in the medical and healthcare field can offer flexible options for those looking to advance or enter new career pathways. For nurses aspiring to the highest levels of practice or academia, there are a range of online nursing doctoral programs available. These programs are designed to fit the schedules of busy professionals and can significantly enhance career opportunities.

Nurses aiming to move up the clinical ladder often consider the most affordable accredited online rn to bsn programs. These bridge programs help registered nurses earn a bachelor’s degree with minimal time spent away from work.

For those from non-nursing backgrounds, the cheapest direct entry msn programs offer a pathway to advanced nursing roles without first earning a BSN. This option can accelerate entry into the nursing profession at a master’s level.

Additionally, aspiring nurses seeking accessible and flexible education options may benefit from online adn programs, which can be a quicker and less competitive route into registered nursing.

Best Scientists Citing Gaston K. Rivera

Trending Scientists

Recently Published Articles